Twin Tree Management, LP Blueprint Medicines Corp Call Options Transaction History

Twin Tree Management, LP

  • $50 Billion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$84.1 - $120.5 $14 Million - $20.1 Million
166,800 Added 98.35%
336,400 $31.1 Million
Q2 2024

Aug 13, 2024
BUY
$85.18 - $108.78 $12.9 Million - $16.5 Million
151,900 Added 858.19%
169,600 $18.3 Million
Q1 2024

May 09, 2024
BUY
$73.17 - $99.79 $1.3 Million - $1.77 Million
17,700 New
17,700 $1.68 Million

Others Institutions Holding BPMC

# of Institutions
352
Shares Held
60.3M
Call Options Held
2.25M
Put Options Held
1.18M
View Full List

About Blueprint Medicines Corp

BPMC Quotes by TradingView
  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.64B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Twin Tree Management, LP Portfolio

Follow Twin Tree Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Twin Tree Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email